维普中文期刊产品整合服务
8篇 您的检索式:作者名="HarzstarkAL"
    题名 作者 年代 出处 被引量
1Ixabepilone, mitoxantrone, and prednisone for metastatic castration-resistant prostate cancerafter doceraxel-based therapy: a phase 2 study of the Department of Defense Prostate Cancer Clinical Trials Con- sortium显示文摘Harzstark AL Rosenberg JE Weinberg VK 2011Cancer2011,117,11:1
2Immunotherapeutics in development for prostate cancer显示文摘Harzstark AL Small EJ 0,,:1
3Ixabepilone, mitoxantrone, and prednisone for metastatic castration-resistant prostate cancerafter docetaxel-based therapy: a phase 2 study of the Department Of Defense Prostate Cancer Clin- ical Trials Consortium显示文摘HARZSTARK AL ROSENBERGJE WEINBERG VK 2011Cancer2011,17,11:1
4A phase I study of sorafenib and RAD001 for metastatic clear cell renal cell carcinoma 显示文摘Harzstark A Rosenberg J Weinberg V 2009J Clin Oncol2009,27,15:1
5Immunotherapy for prostate cancer using antigen-loaded antigen-presenting cells: APC8015 (Provenge) 显示文摘Harzstark AL Small EJ 2007Expert Opin Biol Ther2007,7,:1
6Final results of a phase I study of CTLA-4 blockade in combination with GM-CSF for metastatic castration resistant prostate cancer (mCRPC)显示文摘HarzstarkAL FongL WeinbergVK 2010J Clin 0ncol2010,28,:1
7Five - year survival in patients with cytoking- refractory metastatic renal cell caicinoma treated with axitinib 显示文摘Rini BI de La Moire Rouge T Harzstark AL 2013Clin Genitourin Cancer2013,11,2:1
8Sipuleucel-T for the treatment of prostate cancer显示文摘Harzstark Air and Small EJ 2008Dings Today (Bare)2008,44,4:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费